市場調査レポート
商品コード
1083070

甲状腺未分化癌治療薬の世界市場:2022年~2026年

Global Anaplastic Thyroid Cancer Drugs Market 2022-2026

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
甲状腺未分化癌治療薬の世界市場:2022年~2026年
出版日: 2022年05月25日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の甲状腺未分化癌治療薬の市場規模は、2022年~2026年の間に2億3,053万米ドルの増加が見込まれ、予測期間中に5.44%のCAGRで成長すると予測されています。

同市場は、甲状腺がんの高い有病率、標的療法の導入、老年人口の増加により牽引されています。

当レポートでは、世界の甲状腺未分化癌治療薬市場について調査分析し、全体的な分析、市場規模と予測、動向、成長促進要因、課題、および約25社のベンダーをカバーするベンダー分析を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模(2021年)
  • 市場の見通し:2021年~2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第5章 製品別の市場セグメンテーション

  • 市場セグメント
  • 製品別の比較
  • 化学療法:市場規模と予測(2021年~2026年)
  • 新規療法:市場規模と予測(2021年~2026年)
  • 製品別の市場機会

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別の情勢

  • 地域別のセグメンテーション
  • 地域別の比較
  • 北米:市場規模と予測(2021年~2026年)
  • 欧州:市場規模と予測(2021年~2026年)
  • アジア:市場規模と予測(2021年~2026年)
  • その他の地域(ROW):市場規模と予測(2021年~2026年)
  • 米国:市場規模と予測(2021年~2026年)
  • イタリア:市場規模と予測(2021年~2026年)
  • 中国:市場規模と予測(2021年~2026年)
  • カナダ:市場規模と予測(2021年~2026年)
  • インド:市場規模と予測(2021年~2026年)
  • 地域情勢別の市場機会

第8章 促進要因・課題・動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱情勢
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Eisai Co. Ltd.
  • Johnson and Johnson
  • Medtronic Plc
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • Viatris Inc.

第11章 付録

目次
Product Code: IRTNTR73529

Technavio has been monitoring the anaplastic thyroid cancer drugs market and it is poised to grow by $ 230.53 mn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our report on the anaplastic thyroid cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by high prevalence of thyroid cancer, introductions of targeted therapies, and rising geriatric population.

The anaplastic thyroid cancer drugs market analysis includes the product segment and geographic landscape.

Technavio's anaplastic thyroid cancer drugs market is segmented as below:

By Product

  • Chemotherapy
  • Novel therapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing awareness of thyroid cancer as one of the prime reasons driving the anaplastic thyroid cancer drugs market growth during the next few years. Also, strong pipeline and reimbursement policies for chemotherapy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on anaplastic thyroid cancer drugs market covers the following areas:

  • Anaplastic thyroid cancer drugs market sizing
  • Anaplastic thyroid cancer drugs market forecast
  • Anaplastic thyroid cancer drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anaplastic thyroid cancer drugs market vendors that include Akorn Inc., Amneal Pharmaceuticals Inc., Bayer AG, Bristol Myers Squibb Co., Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Exelixis Inc., Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Medtronic Plc, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc. Also, the anaplastic thyroid cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 26: Chart on Comparison by Product
  • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Chemotherapy - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • 5.4 Novel therapy - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Novel therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Novel therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Novel therapy - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Novel therapy - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product
  • Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Italy - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Italy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Italy - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Italy - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 India - Market size and forecast 2021-2026
  • Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Bayer AG
  • Exhibit 85: Bayer AG - Overview
  • Exhibit 86: Bayer AG - Business segments
  • Exhibit 87: Bayer AG - Key offerings
  • Exhibit 88: Bayer AG - Segment focus
  • 10.4 Bristol Myers Squibb Co.
  • Exhibit 89: Bristol Myers Squibb Co. - Overview
  • Exhibit 90: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 91: Bristol Myers Squibb Co. - Key offerings
  • 10.5 Eisai Co. Ltd.
  • Exhibit 92: Eisai Co. Ltd. - Overview
  • Exhibit 93: Eisai Co. Ltd. - Business segments
  • Exhibit 94: Eisai Co. Ltd. - Key offerings
  • Exhibit 95: Eisai Co. Ltd. - Segment focus
  • 10.6 Johnson and Johnson
  • Exhibit 96: Johnson and Johnson - Overview
  • Exhibit 97: Johnson and Johnson - Business segments
  • Exhibit 98: Johnson and Johnson - Key news
  • Exhibit 99: Johnson and Johnson - Key offerings
  • Exhibit 100: Johnson and Johnson - Segment focus
  • 10.7 Medtronic Plc
  • Exhibit 101: Medtronic Plc - Overview
  • Exhibit 102: Medtronic Plc - Business segments
  • Exhibit 103: Medtronic Plc - Key news
  • Exhibit 104: Medtronic Plc - Key offerings
  • Exhibit 105: Medtronic Plc - Segment focus
  • 10.8 Merck KGaA
  • Exhibit 106: Merck KGaA - Overview
  • Exhibit 107: Merck KGaA - Business segments
  • Exhibit 108: Merck KGaA - Key news
  • Exhibit 109: Merck KGaA - Key offerings
  • Exhibit 110: Merck KGaA - Segment focus
  • 10.9 Novartis AG
  • Exhibit 111: Novartis AG - Overview
  • Exhibit 112: Novartis AG - Business segments
  • Exhibit 113: Novartis AG - Key offerings
  • Exhibit 114: Novartis AG - Segment focus
  • 10.10 Pfizer Inc.
  • Exhibit 115: Pfizer Inc. - Overview
  • Exhibit 116: Pfizer Inc. - Product / Service
  • Exhibit 117: Pfizer Inc. - Key news
  • Exhibit 118: Pfizer Inc. - Key offerings
  • 10.11 Takeda Pharmaceutical Co. Ltd.
  • Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 10.12 Viatris Inc.
  • Exhibit 123: Viatris Inc. - Overview
  • Exhibit 124: Viatris Inc. - Business segments
  • Exhibit 125: Viatris Inc. - Key offerings
  • Exhibit 126: Viatris Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 127: Inclusions checklist
  • Exhibit 128: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 129: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 130: Research methodology
  • Exhibit 131: Validation techniques employed for market sizing
  • Exhibit 132: Information sources
  • 11.5 List of abbreviations
  • Exhibit 133: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Product - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Product - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Product
  • Exhibits27: Data Table on Comparison by Product
  • Exhibits28: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Novel therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Novel therapy - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Novel therapy - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Novel therapy - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Product ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Italy - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Italy - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Italy - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Bayer AG - Overview
  • Exhibits86: Bayer AG - Business segments
  • Exhibits87: Bayer AG - Key offerings
  • Exhibits88: Bayer AG - Segment focus
  • Exhibits89: Bristol Myers Squibb Co. - Overview
  • Exhibits90: Bristol Myers Squibb Co. - Product / Service
  • Exhibits91: Bristol Myers Squibb Co. - Key offerings
  • Exhibits92: Eisai Co. Ltd. - Overview
  • Exhibits93: Eisai Co. Ltd. - Business segments
  • Exhibits94: Eisai Co. Ltd. - Key offerings
  • Exhibits95: Eisai Co. Ltd. - Segment focus
  • Exhibits96: Johnson and Johnson - Overview
  • Exhibits97: Johnson and Johnson - Business segments
  • Exhibits98: Johnson and Johnson - Key news
  • Exhibits99: Johnson and Johnson - Key offerings
  • Exhibits100: Johnson and Johnson - Segment focus
  • Exhibits101: Medtronic Plc - Overview
  • Exhibits102: Medtronic Plc - Business segments
  • Exhibits103: Medtronic Plc - Key news
  • Exhibits104: Medtronic Plc - Key offerings
  • Exhibits105: Medtronic Plc - Segment focus
  • Exhibits106: Merck KGaA - Overview
  • Exhibits107: Merck KGaA - Business segments
  • Exhibits108: Merck KGaA - Key news
  • Exhibits109: Merck KGaA - Key offerings
  • Exhibits110: Merck KGaA - Segment focus
  • Exhibits111: Novartis AG - Overview
  • Exhibits112: Novartis AG - Business segments
  • Exhibits113: Novartis AG - Key offerings
  • Exhibits114: Novartis AG - Segment focus
  • Exhibits115: Pfizer Inc. - Overview
  • Exhibits116: Pfizer Inc. - Product / Service
  • Exhibits117: Pfizer Inc. - Key news
  • Exhibits118: Pfizer Inc. - Key offerings
  • Exhibits119: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits120: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits123: Viatris Inc. - Overview
  • Exhibits124: Viatris Inc. - Business segments
  • Exhibits125: Viatris Inc. - Key offerings
  • Exhibits126: Viatris Inc. - Segment focus
  • Exhibits127: Inclusions checklist
  • Exhibits128: Exclusions checklist
  • Exhibits129: Currency conversion rates for US$
  • Exhibits130: Research methodology
  • Exhibits131: Validation techniques employed for market sizing
  • Exhibits132: Information sources
  • Exhibits133: List of abbreviations